Controlled Release Drug Delivery Market Size
The Global Controlled Release Drug Delivery Market reached USD 50.9 billion in 2022 and The global controlled release drug delivery market is expected to exhibit a CAGR of 9.2% during the forecast period (2024-2031).
Controlled release drug delivery devices hold a distinct advantage over traditional drug administration methods.
The shift in physicians’ prescribing habits towards these controlled release systems, due to their high therapeutic effectiveness, enhanced patient adherence, and reduced treatment costs, is anticipated to fuel the expansion of the controlled release drug delivery market.
Moreover, the market for controlled release drug delivery is experiencing rapid growth due to several factors, including increased therapeutic effectiveness, reduced side effects, lower treatment costs, and ongoing research and development activities. The market is witnessing a surge in demand from North American regions, such as the U.S. and Canada, due to their substantial healthcare spending. Key market players include Coating Place, Inc, Corium International, Inc, Depomed, Inc, among others.
For More Insights Request Free Sample: https://www.datamintelligence.com/download-sample/controlled-release-drug-delivery-market
-
Polymer-based drug delivery system
-
Activation modulated drug delivery system
-
Chemically activated drug delivery system
-
Wurster technique
-
Micro encapsulation
-
Coacervation
-
Targeted delivery
-
Others
By Route of Administration
Major players are Johnson and Johnson, Coating Place, Inc, Corium International, Inc, Depomed, Inc, Pfizer, Inc, Biogen, GlaxoSmithKline, Novartis, Orbis Biosciences, Inc., Merck and Co.
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian